1Thorne, Grace M, Alder, Jeff. Daptomycin: a novel lipopeptide antibiotic [J]. Clinical Microbiology Newsletter. 2002, 24(5): 33
2Canepari, P., M. Boaretti, M. del Mar Lleo, et al.Lipoteichoic acid as a new target for activity of antibiotics:mode of action of daptomycin (LY146032). Antimicrob[J]. Agents Chemother, 1990, 34:1220
3Alborn WE Jr, Allen NE, Preston DA. Daptomycin disrupts membrane potential in growing Staphylococcus aureus [J].Antimicrob Agents Chemother, 1991 Nov, 35 (11):2282
4Silverman JA, Oliver N, Andrew T, et al. Resistance studies with daptomycin [J]. Antimicrob Agents Chemother. 2001, 45 (6): 1799
5Hill J, Siedlecki J, Parr I, et al. Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin[J]. Bioorg Med Chem Lett, 2003, 1; 13(23): 4187
6Debono, M. , M. Barnhart, C. B. Carrell, J. A. Hoffman,J. L. Occolowitz, B. J. Abbott, D. S. Fukuda, and R. L.Hamill. 1987. A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation. J. Antibiot. 40:761
7M. A. Mehenney, T. J. Hosted, B. S. Dehoff, et al.Molecular Cloning and Physical Mapping of the Daptomycin Gene Cluster from Streptomyces roseosporus [J]. J.Bacteriol. , 1098, 180 (1): 143
8Miao Vivian Pak Woon (CA) . Compositions and methods relating to the daptomycin biosynthetic gene duster..WO03014297. 2003-02-20
9Hosted, T. J. , and R. H. Baltz. Use of rpsL for dominance selection and gene replacement in Streptomyces roseosporus[J], J. Bacteriol, 1997, 179:180
4Barry A L, Fuchs P C & Brown S D. In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers[J]. Antimicrob Agents Chemother 2001,45 (6) :1919.
5Akins R L & Rybak M J. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediateresistant Staphylococcus aureus ,vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with stimulated endocardial vegetations[J]. J Antimicrob Chemother,2001,48(2) : 454.
6King A & Phillips I. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical [J]. J Antimicrob Chemother, 2001,48(2):219.
7Silverman J A Oliver N, Andrew T et al, Resistance studies with daptomycin[J]. Antimicrob Agents Chemother, 2001,45 (6) : 1799.
8Debono M, Abbott B J, Molloy R Met al Enzymatic and chemical modifications pf lipopeptide antibiotic A21978C:the synthesis and evaluation of daptomycin (LY146032) [J]. J Antibiotic, 1988, 41(8):1093.
9Boeck L D Papiska H R, Wetzel R Wet al, A54145. a new lipopeptide antibiotic complex: discovery, taxonomy, fermentation and HPLC [J] ,J Antibiotic, 1990,43(6) : 587.
8Kirkpatrick P, Raja A, LaBonte J, et al. Daptomycin[J]. Nature Rev Drug Discov, 2003, 2 (12) : 942-943.
9Debono M, Abbott B J, Molloy MR, et al. Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032) [J]. JAntibiot, 1988, 41 (8): 1093-1105.
